BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Receives $16.71 Average Target Price from Analysts
Shares of BioXcel Therapeutics, Inc. (NASDAQ:BTAI – Get Free Report) have been given an average recommendation of “Hold” by the seven brokerages that are presently covering the firm, MarketBeat Ratings reports. Four analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 12 month […]
More Stories
Cohen & Steers Closed-End Opportunity Fund, Inc. (FOF) To Go Ex-Dividend on January 14th
Cohen & Steers Closed-End Opportunity Fund, Inc. (NYSE:FOF – Get Free Report) announced a dividend on Monday, January 13th,investing.com reports....
InnSuites Hospitality Trust (IHT) To Go Ex-Dividend on January 24th
InnSuites Hospitality Trust (NYSE:IHT – Get Free Report) declared a semi-annual dividend on Monday, January 13th,Wall Street Journal reports. Investors...
Neuberger Berman Real Estate Securities Income Fund Inc. (NYSEAMERICAN:NRO) Announces $0.03 Monthly Dividend
Neuberger Berman Real Estate Securities Income Fund Inc. (NYSEAMERICAN:NRO – Get Free Report) announced a monthly dividend on Monday, January...
Aberdeen Total Dynamic Dividend Fund (AOD) To Go Ex-Dividend on January 24th
Aberdeen Total Dynamic Dividend Fund (NYSE:AOD – Get Free Report) declared a monthly dividend on Monday, January 13th,Wall Street Journal...
Option Care Health (NASDAQ:OPCH) Issues FY25 Earnings Guidance
Option Care Health (NASDAQ:OPCH – Get Free Report) updated its FY25 earnings guidance on Monday morning. The company provided earnings...
Flowers Foods (NYSE:FLO) Sets New 52-Week Low – Here’s Why
Flowers Foods, Inc. (NYSE:FLO – Get Free Report)’s stock price reached a new 52-week low during trading on Monday ....